TipRanks
Bioxcel Therapeutics (DE:BX20)
HAMBURG:BX20
Germany Market
BX20
Bioxcel Therapeutics
RESEARCH TOOLSreports

Bioxcel Therapeutics (BX20) Income Statement

10 Followers

Bioxcel Therapeutics Income Statement

Last quarter (Q2 2026), Bioxcel Therapeutics's total revenue was $182.00K, an increase of 51.67% from the same quarter last year. In Q2, Bioxcel Therapeutics's net income was $-14.71M. See Bioxcel Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 642.00K$ 2.27M$ 1.38M$ 375.00K$ 0.00
Gross Profit
$ 478.00K$ 123.00K$ 120.00K$ 355.00K$ 0.00
Operating Expenses
$ 50.74M$ 67.37M$ 171.90M$ 160.00M$ 106.94M
Depreciation and Amortization
$ 300.00K$ 309.00K$ 318.00K$ 327.00K$ 297.00K
EBITDA
$ -52.61M$ -44.16M$ -165.42M$ -157.22M$ -106.59M
Operating Income
$ -50.27M$ -67.25M$ -171.78M$ -159.65M$ -106.94M
Other Income/Expenses
$ -19.63M$ 7.65M$ -7.27M$ -6.11M$ 3.00K
Pretax Income
$ -69.90M$ -59.60M$ -179.05M$ -165.76M$ -106.93M
Net Income
$ -69.90M$ -59.60M$ -179.05M$ -165.76M$ -106.93M
Per Share Metrics
Basic EPS
$ -5.73$ -23.51$ -98.35$ -94.67$ -64.87
Diluted EPS
$ -5.73$ -23.51$ -98.35$ -94.67$ -64.87
Weighted Average Shares Outstanding
 12.21M 2.54M 1.82M 1.75M 1.65M
Weighted Average Shares Outstanding (Diluted)
 12.21M 2.54M 1.82M 1.75M 1.65M
Currency in USD

Bioxcel Therapeutics Earnings and Revenue History